Radiosynovectomy

Quick Answer

Radiosynovectomy (radiosynoviorthesis) is the intra-articular injection of a beta-emitting colloid/particulate to ablate inflamed synovium in chronic refractory synovitis — rheumatoid and other inflammatory arthritides, and hemophilic arthropathy. The defining principle is matching the isotope's beta range (penetration) to joint size: Y-90 for large joints (knee), Re-186 for medium joints, and Er-169 for small (finger) joints. The dominant safety concern is extra-articular leakage to regional nodes — minimized by particulate agents, correct placement, and joint rest.

Background & Mechanism

Persistently inflamed synovium (pannus) drives pain, effusion, and joint destruction. A beta-emitting radiocolloid injected into the joint is phagocytosed by synovial lining cells, delivering a high local β dose that ablates the inflamed synovium (radiation synoviorthesis) — a radiation analogue of surgical/chemical synovectomy, without surgery.

Match the Isotope to the Joint

Too penetrating an isotope in a small joint irradiates cartilage/skin; too shallow an isotope in a large joint under-treats thick synovium — hence the size match.

Indications

• Chronic, refractory synovitis unresponsive to systemic/intra-articular medical therapy: rheumatoid arthritis, other inflammatory arthropathies, pigmented villonodular synovitis, and recurrent hemarthrosis in hemophilia (hemophilic arthropathy).

Contraindications & Cautions

• Pregnancy/lactation; local skin infection; ruptured Baker cyst or major joint instability (leakage risk).
• Young age — relative caution (theoretical stochastic risk); document justification.

Administration & Practicalities

• Image/aspirate under guidance; confirm intra-articular placement (contrast/tracer) before injecting the therapeutic colloid — often co-injected with a corticosteroid.
• Joint immobilization/rest (~48–72 h) after injection to minimize lymphatic leakage of the colloid to regional nodes.
• Post-injection imaging (Y-90 bremsstrahlung, Re-186 γ) can confirm distribution.

Toxicity / Risks

• Extra-articular leakage to draining nodes (dose to nodes; the main radiation-safety concern) — worse with soluble/small particles, poor placement, or early mobilization.
• Radiation necrosis/skin effects from misplaced injection; transient post-injection inflammation.

Reporting / Documentation

• Document isotope choice matched to joint size, confirmed intra-articular placement, co-administered steroid, and immobilization instructions.

Common Pitfalls

• Mismatching isotope to joint size (Y-90 in a finger; Er-169 in a knee).
• Extravasation / extra-articular injection → node leakage and poor efficacy.
• Skipping post-injection joint rest, increasing lymphatic leakage.

Board Pearls

Radiosynovectomy injects a beta-emitting colloid into a joint to ablate inflamed synovium in refractory synovitis (RA, hemophilic arthropathy). The defining rule is match beta range to joint size: Y-90 → large (knee), Re-186 → medium, Er-169 → small (fingers) — too penetrating an isotope in a small joint harms cartilage/skin; too shallow in a large joint under-treats.

The dominant safety concern is extra-articular leakage of colloid to regional lymph nodes — minimized by particulate agents, confirmed intra-articular placement, and ~48–72 h joint immobilization after injection. A corticosteroid is often co-injected.

The colloid is phagocytosed by synovial lining cells, delivering local β dose (radiation synoviorthesis). Post-injection imaging (Y-90 bremsstrahlung, Re-186 γ) confirms distribution. Relative caution in young patients (stochastic risk); contraindicated in pregnancy, local infection, and unstable/ruptured joints (leakage).

Related Pages

• Physics: radiation biology & protection (beta shielding); therapy: bone-pain palliation (other beta therapy).

Figure / Diagram Suggestions

• An isotope-to-joint-size matching chart (β range vs joint).
• A synovial phagocytosis → synoviorthesis mechanism cartoon.

Self-Check